Topical retinoids for acne

Lindsey Yeh, Lauren Meshkov Bonati, Nanette B. Silverberg

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Topical retinoids are currently approved by the US Food and Drug Administration for the treatment of acne vulgaris in nonpregnant, nonlactating patients 12 years of age and older. Their efficacy, safety, and tolerability are well documented for inflammatory and noninflammatory acne with studies repeatedly demonstrating a decrease in the number of lesions, significant improvement in acne severity, improvement in the cosmetic appearance of acne, and the prevention of acne lesions through microcomedone formation. There is some variability between prescription retinoid products regarding efficacy, safety, and tolerability; with erythema, peeling, and dryness being common, potential side effects. Due to their efficacious and safe profile, topical retinoids remain the first-line treatment for acne vulgaris.

Original languageEnglish
Pages (from-to)50-56
Number of pages7
JournalSeminars in Cutaneous Medicine and Surgery
Volume35
Issue number2
DOIs
StatePublished - 1 Jun 2016

Fingerprint

Dive into the research topics of 'Topical retinoids for acne'. Together they form a unique fingerprint.

Cite this